Skip to content

Prospective observational study on the effect and influencing factors of modified electroconvulsive therapy in adolescents with mood disorders associated with non-suicidal self-injury behavior (NSSI)

Prospective observational study on the effect and influencing factors of modified electroconvulsive therapy in adolescents with mood disorders associated with non-suicidal self-injury behavior (NSSI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080872
Enrollment
Unknown
Registered
2024-02-09
Start date
2024-02-15
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mood disorders

Interventions

Experimental group (Patients treated with drugs combined with MECT):None
Control group (Patients treated with drugs):None

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 24 Years

Inclusion criteria

Inclusion criteria: (1) Inpatients, aged 14-24 years old (including 14 and 24 years old), regardless of gender; (2) Meet the diagnostic criteria of ICD-10 for mood disorders; (3) accompanied by non-suicidal self-injury behaviors (the frequency of 12 kinds of self-injury behaviors in the past year was investigated by the questionnaire of non-suicidal self-injury behaviors, and the cumulative frequency of various self-injury behaviors was =5 times); (4) primary school education, can understand the content of the scale; (5) The informed consent shall be signed by the patient and the guardian at the age of 14 to 17, and the informed consent shall be signed by the patient himself at the age of 18 to 24.

Exclusion criteria

Exclusion criteria: (1) Patients considered by the investigator to be at serious risk of suicide and assessed by the investigator to be unsuitable for inclusion in this study; (2) There are currently serious physical diseases, and the researchers believe that they are not suitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Effective rate;

Secondary

MeasureTime frame
Complete remission;Therapeutic effect;

Countries

China

Contacts

Public ContactZhou Jia

Beijing Anding Hospital, Capital Medical University

sophie_2020@ccmu.edu.cn+86 156 5265 7661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026